AMICUS THERAPEUTICS, INC.
David M. Clark
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David M. Clark
AMICUS THERAPEUTICS, INC. reported in an 8-K filed April 27, 2026 that David M. Clark resigned as executive officer, effective April 27, 2026. The proxy statement of AMICUS THERAPEUTICS, INC. reports total compensation of $3,214,599 for David M. Clark in fiscal 2023, including a base salary of $469,059. Disclosed compensation is on record for 2 fiscal years.
“In connection with the consummation of the Merger, as of the Effective Time, all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
AMICUS THERAPEUTICS, INC.
Proxy statement
Start not stated–2026-04-27
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | AMICUS THERAPEUTICS, INC. | Chief People Officer | $469,059 | $3,214,599 |
| 2022 | AMICUS THERAPEUTICS, INC. | Chief People Officer | $453,238 | $2,708,063 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.